[Phase II study with etoposide/vincristine in small cell bronchial cancer (extensive disease)].
The remission rates achieved with the combination of vincristine and etoposide are comparable with other frequently employed therapeutic regimens (ACO/EPICO, cisplatin/etoposide). The combination of etoposide with vincristine represents an alternative, in particular with respect to a merely palliative approach to treatment.
Zentralkrankenhaus Gauting/München.
J
J
von Pawel
H
H
Wilke
D
D
Vallée
H
H
Dimbeck
H J
HJ
Schmoll
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D018288:Carcinoma, Small Cell / Q000188:drug therapy*; D004341:Drug Evaluation; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010166:Palliative Care; D014750:Vincristine / Q000008:administration & dosage
D014750:Vincristine; D005047:Etoposide
Phase-II-Studie mit Etoposide/Vincristin beim kleinzelligen Bronchialkarzinom (extensive disease).